The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or metastatic hormone receptor HR+, HER2- breast cancer in adult patients who have previously received endocrine-based therapy and chemotherapy for unresectable or metastatic disease, according to a news release.

Danielle Fishel is sharing an update about her health, saying she has completed “active cancer treatment” following her announcement in August that she was diagnosed with DCIS, which stands for ductal carcinoma in situ and is a form of breast cancer.

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic and breast cancer.

The Breast Cancer Risk Assessment Tool (BCRAT), also known as The Gail Model, is a tool used by healthcare professionals to estimate a woman's risk of developing invasive breast cancer within the next five years and within her lifetime (up to age 90), according to the National Cancer Institute.

Flossmoor resident and cancer survivor Ann Jackson launched the Center for Food Equity in Medicine at Flossmoor Community Church.

Dr. Liz O'Riordan wants people to know that there is no "magic fix" and no special diet that will cure cancer, despite many of the online claims out there.

Cancer diagnoses are shifting from older to younger adults and from men to women, according to a report released Thursday by the American Cancer Society.

Breast Cancer Now said olaparib will be an ‘valuable alternative’ for patients with a certain type of secondary breast cancer.

A new resource from the National Comprehensive Cancer Network (NCCN) provides evidence-based guidance on assessing and testing for inherited genetic mutations linked with increased cancer risk.

Many women worry hormonal contraceptives have dangerous side-effects including increased cancer risk. But this perception is often out of proportion with the actual risks.

Individuals with cardiovascular disease could have an increased risk for advanced breast cancer at diagnosis, potentially guiding recommendations for personalized screening.

Artificial Intelligence can improve breast cancer detection and reduce workload on physicians, according to a new study from Germany featuring over 461,000 women.